Your SlideShare is downloading. ×
0
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report

2,304

Published on

Australian Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts …

Australian Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.

Shares Scanned 25th June 2010.

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,304
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pharmaceuticals, Biotechnology and Life Sciences - Australian Stock Market Report
  • 2. ACTINOGEN LIMITED <ul><li>Actinogen (ACW) is involved in the commercialisation of bioactive compounds. </li></ul>
  • 3. ADVANCED OCULAR SYSTEMS LIMITED <ul><li>Advanced Ocular Systems (AOS) is a biotechnology company engaged in the development of ophthalmology products and ophthalmic research. </li></ul>
  • 4. AGENIX LIMITED <ul><li>Agenix (AGX) is an Australian-based company engaged in the research and development of biotechnology. </li></ul>
  • 5. ALCHEMIA LIMITED <ul><li>Alchemia (ACL) is a biotechnology company. </li></ul>
  • 6. AMBRI LIMITED <ul><li>Ambri (ABI) is a biotechnology development company. </li></ul>
  • 7. ANADIS LIMITED <ul><li>Anadis (ANX) is a bio-pharmaceutical research and development company. </li></ul>
  • 8. ANTISENSE THERAPEUTICS LIMITED <ul><li>Antisense Therapeutics Limited (ANP) is an Australian-based company operating mainly in the health care industry. Antisense is engaged in the creation, development and commercialisation of the antisense pharmaceuticals. </li></ul>
  • 9. APOLLO LIFE SCIENCES LIMITED <ul><li>Apollo Life Sciences (AOP) specialises in biotechnology. The Company develops, manufactures and markets therapeutics based on human proteins. </li></ul>
  • 10. ARANA THERAPEUTICS LIMITED <ul><li>Arana Therapeutics (AAH) is a global biopharmaceutical Company actively involved in the research, development, production and distribution of peptide based medical products for use in the pharmaceutical and veterinary industries. </li></ul>
  • 11. AVANTOGEN LIMITED <ul><li>ACU is an international biotechnology company developing a product portfolio of a broad range of oncology-related products. </li></ul>
  • 12. AVEXA LIMITED <ul><li>Avexa (AVX) is a drug-discovery company principally engaged in the research and development of anti-infectives. Avexa's core focus is on the research, discovery and development of innovative medicines for the cure of the diseases caused by Human Immunodeficiency Virus (HIV) and Vancomycin- and methicillin-resistant bacteria. </li></ul>
  • 13. BENITEC LIMITED <ul><li>Benitec (BLT) is a biotechnology research and development company, involved in developing therapeutics for serious diseases. </li></ul>
  • 14. BIODIEM LIMITED <ul><li>BioDiem is a Melbourne-based pharmaceutical development company, developing a portfolio of promising later stage projects from world-class research institutes. </li></ul>
  • 15. BIONOMICS LIMITED <ul><li>Bionomics (BNO) is a biotechnology company creating small molecule drugs to treat cancer and disorders of the central nervous system. </li></ul>
  • 16. BIOPHARMICA LIMITED <ul><li>BPH is a biotechnology company specialising in the development of cancer treatments. </li></ul>
  • 17. BIOPROSPECT LIMITED <ul><li>BioProspect (BPO) is a Brisbane based company focused on the discovery of new pharmaceutical, nutraceutical and agrochemical products from natural sources. </li></ul>
  • 18. BIOSIGNAL LIMITED <ul><li>BioSignal (BOS) was established to commercialise a proprietary technology based on anti-bacterial and anti-fouling compounds called &quot;furanones&quot; found in a seaweed. BOS's Furanones are naturally derived compounds that reduce a bacteria’s ability to attach to innate surfaces (such as pipes, ship hulls) and animate surfaces (such as lungs, skin and teeth). </li></ul>
  • 19. BIOTA HOLDINGS LIMITED <ul><li>Biota Holdings (BTA) is a leading anti-infective drug developer. </li></ul>
  • 20. BIOTECH CAPITAL LIMITED <ul><li>Biotech Capital (BTC) is one of Australia's largest biotechnology investment companies. BTC invests in a range of small- to medium-sized biotechnology companies, both listed and unlisted. </li></ul>
  • 21. BIOTRON LIMITED <ul><li>Biotron Limited (BIT) was established to develop research projects on the basis of intellectual property (IP) developed at the Australian National University's John Curtin School of Medical Research (JCSMR). </li></ul>
  • 22. BONE MEDICAL LIMITED <ul><li>Bone Medical (BNE), along with its subsidiaries, is engaged in the development of therapeutics to prevent and/or treat bone and joint diseases and conditions, especially osteoporosis, osteoarthritis and arthritis. </li></ul>
  • 23. CELLESTIS LIMITED <ul><li>Cellestis Limited (CST) is a company engaged in the development, manufacturing as well as marketing of different medical diagnostic products and scientific research </li></ul>
  • 24. CHEMEQ LIMITED <ul><li>Chemeq (CMQ) is a research driven veterinary pharmaceutical company engaged in the development, manufacturing and marketing of its product, CHEMEQ polymeric anti-microbial (CHEMEQ). CHEMEQ is used for the prevention and control of diseases caused in feedstock animals, like pigs and poultry by intestinal bacteria. </li></ul>
  • 25. CHEMGENEX PHARMACEUTICALS LTD <ul><li>ChemGenex Pharmaceuticals (CXS) is an Australia-based biotechnology research and development company engaged in the improving patients' lives through the development of personalised therapeutics in the areas of obesity, cancer, depression and diabetes. </li></ul>
  • 26. CIRCADIAN TECHNOLOGIES LIMITED <ul><li>Circadian Technologies (CIR) is a biotechnology company engaged in the development and commercialisation of biologics-based therapies for the cure of cancer and other serious diseases. </li></ul>
  • 27. CLINUVEL PHARMACEUTICALS LIMITED <ul><li>Clinuvel Pharmaceuticals (CUV) specialises in the manufacturing of biopharmaceuticals and prescription dermatology products. Clinuvel is engaged in the development of its innovative drug candidate afamelanotide. </li></ul>
  • 28. COGSTATE LTD <ul><li>Cogstate (CGS) specialises in the development and commercialisation of rapid, computerised tests for the measurement of cognition (brain function). </li></ul>
  • 29. CRYOSITE LIMITED <ul><li>Cryosite (CTE) provides specialised outsourced logistic services to a range of clients, including the research, medical, pharmaceutical, veterinary and biotechnology industries. </li></ul>
  • 30. CSL LIMITED <ul><li>CSL is a biopharmaceutical conglomerate that develops, manufactures and markets products which act as treatment or prevention against human medical conditions. </li></ul>
  • 31. GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED <ul><li>Genesis Research and Development Corporation (GEN) is a biotechnology company with core technical expertise in the fields of genomics and immunology. </li></ul>
  • 32. GENETIC TECHNOLOGIES LIMITED <ul><li>Genetic Technologies (GTG) is a life science company engaged in the licensing of biotechnology patents as well as specialising in the fields of genomics and genetics with operations in Canada, Switzerland and Australia. </li></ul>
  • 33. GIACONDA LIMITED <ul><li>Giaconda (GIA) develop medical therapies that provides relief for patients suffering from serious gastointestinal (GI) diseases and disorders. Its product portfolio comprises of four therapeutic products and a pre-colonoscopy bowel preparation. </li></ul>
  • 34. HALCYGEN PHARMACEUTICALS LIMITED <ul><li>HalcyGen Pharmaceuticals Limited (HGN) is a company that focuses on testing and improvement of generic drugs. </li></ul>
  • 35. HEALTHLINX LIMITED <ul><li>Healthlinx (HTX) uses its proprietary “Cryptomics” technology to exploit evolutionary protein design to discover hidden or &quot;cryptic&quot; peptide fragments within existing larger proteins. </li></ul>
  • 36. HELICON GROUP LIMITED <ul><li>Helicon Group is involved in the business to identify and exploit niche market opportunities in the Biomedical markets in selected Asian markets with a China priority and to participate in the significant growth that has been projected for these markets over the next 25 years </li></ul>
  • 37. IDT AUSTRALIA LIMITED <ul><li>IDT Australia (IDT) is a specialist pharmaceutical manufacturing company primarily focused on the development, scale-up and manufacturing of active pharmaceutical ingredients (API). </li></ul>
  • 38. IMUGENE LIMITED <ul><li>Imugene (IMU) is an animal health biopharmaceutical company developing and commercialising biological products for the intensively farmed pig and poultry industries. </li></ul>
  • 39. INCITIVE LIMITED <ul><li>Incitive (ICV) is a pharmaceuticals &amp; biotechnology company. Its aim is to become a sustainable Life Science company by in-licensing leads at the discovery stage, taking them through preclinical studies which will create significant value-add, and partner with large pharmaceutical or biotechnology companies for the clinical phase. </li></ul>
  • 40. LIFE THERAPEUTICS LIMITED <ul><li>Life Therapeutics Ltd. (LFE) is a biotechnology company engaged in the research and development, manufacturing and marketing of haemostasis and separation technologies for the life science markets. </li></ul>
  • 41. LIVING CELL TECHNOLOGIES LIMITED <ul><li>Living Cell Technologies (LCT) injects healthy cells to replace or repair damaged organs without the use of toxic drugs. The company targets Huntington's disease, stroke, type 1 diabetes and haemophilia. </li></ul>
  • 42. MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED <ul><li>Medical Developments International (MVP) designs, manufactures and distributes a wide range of equipment, products and devices in the anaesthetics, oxygen delivery, veterinary and asthma management fields. The company also manufactures a pre-hospital and emergency pain relief product, which is used in Australian ambulance services. MDI has three business units: pharmaceutical, medical equipment and veterinary equipment. </li></ul>
  • 43. MESOBLAST LIMITED <ul><li>Mesoblast Limited (MSB) is a biotechnology company committed to the treatments for orthopaedic conditions, including the commercialisation of adult stem cell technology aimed at the regeneration and repair of bone and cartilage. </li></ul>
  • 44. METABOLIC PHARMACEUTICALS LIMITED <ul><li>Metabolic Pharmaceuticals (MBP) is a biotechnology company with around 300 million issued shares. The principal focus of the Company is to take innovative drugs, with strong market potential, through research, formal preclinical and clinical development. </li></ul>
  • 45. NARHEX LIFE SCIENCES LIMITED <ul><li>Narhex Life Sciences (NLS) has developed a new class of protease inhibitors, which are a group of drugs used to treat HIV infection. The lead candidate is DG17, which when ingested is converted to DG35, the molecule with anti-HIV activity. These compounds are covered by issued or filed global patents. </li></ul>
  • 46. NEUREN PHARMACEUTICALS LIMITED <ul><li>Neuren Pharmaceuticals (NEU) is a biopharmaceutical company focused on the development of human therapies for neuroprotection, metabolic deficiencies and growth-related disorders. </li></ul>
  • 47. NEURODISCOVERY LIMITED <ul><li>NeuroDiscovery (NDL) is a global research and development company operating in Life Science. The company focuses on the commercialization and development of opportunities in the field of neurology. </li></ul>
  • 48. NOVOGEN LIMITED <ul><li>Novogen Limited (NRT) is a pharmaceutical company engaged in the development, discovery, manufacturing, and marketing of different health products using the isoflavonoid technology. </li></ul>
  • 49. NUSEP LTD <ul><li>NuSep is a Life Science Separations Company. NuSep’s core competency is in precast gels and laboratory separation processes. Company's goal is to become a leading supplier in the life science separations market. </li></ul>
  • 50. OBJ LIMITED <ul><li>OBJ is a drug delivery company involved in active transdermal (through-skin) drug delivery. OBJ, through its fully owned subsidiary International Scientific Limited, is developing electronic “drug patch” technologies that allow drugs, therapeutic agents and cosmetic compounds to be delivered more effectively and more efficiently through the skin. </li></ul>
  • 51. PATRYS LIMITED <ul><li>Patrys (PAB) is a company that focuses on the development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer. The company has the world-wide, exclusive rights to technologies developed over 25 collective years of research and development that allow the capture, development and production of natural human antibodies for potential therapeutic applications. </li></ul>
  • 52. PHARMAUST LIMITED <ul><li>PharmAust Limited (PAA) is a unique vertically integrated pharmaceutical business involved in a range of activities from contract drug discovery and development to manufacturing, sales and marketing of healthcare & amp; pharmaceutical products. </li></ul>
  • 53. PHARMAXIS LTD <ul><li>Pharmaxis (PXS) is a pharmaceutical company specialising in the research, development and commercialisation of therapeutic pharmaceutical products. The Company manufactures specialty products for use in the diagnosis and treatment of chronic respiratory and immune disorders. </li></ul>
  • 54. PHOSPHAGENICS LIMITED <ul><li>Phosphagenics (POH) is a biotechnology company. The Company focuses on the research, development and commercialisation of products for the nutraceutical and pharmaceutical industries. </li></ul>
  • 55. PHYLOGICA LIMITED <ul><li>Phylogica (PYC) is a biopharmaceutical company engaged in the discovery and development of novel biopharmaceuticals directed at proteins and their interactions. </li></ul>
  • 56. PRANA BIOTECHNOLOGY LIMITED <ul><li>Prana Biotechnology Limited (PBT) is a company engaged in researching about Alzheimer's disease as well as other type of age-related neurodegenerative diseases and disorders. </li></ul>
  • 57. PRIMA BIOMED LTD <ul><li>Prima Biomed (PRR) is an Australian biotechnology company with a portfolio of products focussed in the therapeutic area of cancer. </li></ul>
  • 58. PROBIOMICS LIMITED <ul><li>Probiomics (PCC) is a specialist biotechnology company focused on the development of products incorporating PCC®, a strain of Lactic Acid Bacteria (probiotic). Its probiotic products include Progastrim®, sold exclusively to naturopaths, and proTract®, a family of products for intestinal health, diarrhoea and irritable bowel syndrome and for atopic dermatitis. Both these products are listed on the Australian Register of Therapeutic Goods. </li></ul>
  • 59. PROBIOTEC LIMITED <ul><li>Probiotec (PBP) is a brand owner, manufacturer and distributor of a range of over the counter (OTC) pharmaceuticals, complementary medicines and speciality ingredients. The company comprises the management and marketing of quality brands and intellectual property, as well as pharmaceutical manufacturing including contract manufacturing for third parties. </li></ul>
  • 60. PROGEN PHARMACEUTICALS LIMITED <ul><li>Progen Pharmaceuticals Limited (PGL) is a biotechnology company engaged in discovering, developing as well as commercialising the small molecule pharmaceutical for cancer treatment. </li></ul>
  • 61. PSIVIDA LIMITED <ul><li>pSivida (PVA) is an international bio-nanotech company specialising in the development of drug-delivery products in the healthcare industry, with its core focus on ophthalmology and oncology. </li></ul>
  • 62. QRXPHARMA LTD <ul><li>QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma’s product portfolio includes both late and early stage clinical drug candidates with well-defined paths to regulatory approval and sales. </li></ul>
  • 63. SELECT VACCINES LIMITED <ul><li>Select Vaccines (SLT) is targeting global markets for infectious disease diagnostic and vaccine products. Their core commercial objective is the identification of appropriate corporate partnership opportunities. SLT operates in the global life sciences industry, covering pharamceuticals, biotechnology, in-vitro diagnostics, and research tools. </li></ul>
  • 64. SIGMA PHARMACEUTICALS LIMITED <ul><li>Sigma Pharmaceuticals Limited (SIP) is a company engaged in manufacturing, marketing and distributing pharmaceutical products through drugstore and grocery channels. </li></ul>
  • 65. SIRTEX MEDICAL LIMITED <ul><li>Sirtex Medical (SRX) is a biotechnology and medical device company. The Company is principally focused on the research and commercial development of liver cancer treatments using small particle technology. The Company supplies its product to a number of markets in Asia-Pacific, Europe and the United States of America. </li></ul>
  • 66. SOLAGRAN LIMITED <ul><li>Solagran (SLA) is a Melbourne-based biotechnology company established in 1995 to commercialise a series of natural, biologically active compounds known as Bioeffectives. </li></ul>
  • 67. STARPHARMA HOLDINGS LIMITED <ul><li>Starpharma Holdings (SPL) is a world leading developer of nanotechnology-based pharmaceuticals operating in Australia and United States. The Company develops and commercialises dendrimer products for use in pharmaceutical, life-science and other applications. </li></ul>
  • 68. STIRLING PRODUCTS LIMITED <ul><li>Stirling Products (STI) specialises in the late stage development and commercialisation of medicated animal feed products for more effective and safer animal growth promotion. STI's products are being positioned as a major influence in reducing the use of antibiotics and steroids by offering a safer and more effective alternative for animal growth promotion across a number of different livestock species. </li></ul>
  • 69. TISSUE THERAPIES LIMITED <ul><li>Tissue Therapies (TIS) is biotechnology company that provides wound healing, tissue repair and cell culture technology through a growth factor platform technology VitroGro. </li></ul>
  • 70. VIRALYTICS LIMITED <ul><li>Viralytics (VLA), formerly Psiron Ltd, is a biotechnology company focused on the development and commercialisation of virotherapy technology for treatment of cancer. The virotherapy technology uses naturaly ocuring viruses such as Coxsackievirus and Echovirus which is associated with the common cold. </li></ul>
  • 71. VIRAX HOLDINGS LIMITED <ul><li>Virax Holdings (VHL) is an Australian biotechnology company developing immune based therapies that direct the immune system to treat a broad range of diseases. The company is dedicated to developing a new class of immunotherapeutics to treat widespread, life-threatening diseases of the immune system including HIV/AIDS and other infectious diseases, cancers and autoimmune disease. </li></ul>
  • 72. VITA LIFE SCIENCES LIMITED. <ul><li>Vita Life Sciences (VSC) is a successful Australian owned pharmaceutical and healthcare company servicing clients throughout Asia and Australia. </li></ul>
  • 73. XCEED CAPITAL LIMITED. <ul><li>Xceed Capital (XCD) is biotechnology investment company focusing on investments in revenue-producing and research based, leading-edge patentable technologies. The company will initially focus on the development and commercialisation of novel biodegradable polymers; and increasing sales of its and its collaborative partners' products range. </li></ul>

×